51 days until earnings call
Interact to see
Advertisement
Advertisement
EFAV vs GSK
EFAV vs GSK Comparison
Open Charts EFAV vs GSK
iShares MSCI EAFE Min Vol Factor ETF
Price$85.87
Change+$0.44 (+0.52%)
Volume$9.84K
Net Assets5.43B
EFAV vs GSK Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
EFAV vs. GSK commentary
Sep 09, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EFAV is a StrongBuy and GSK is a StrongBuy.
SUMMARIES
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 7 Undervalued | |
PROFIT vs RISK RATING 1..100 | 62 | |
SMR RATING 1..100 | 40 | |
PRICE GROWTH RATING 1..100 | 52 | |
P/E GROWTH RATING 1..100 | 26 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TECHNICAL ANALYSIS
Technical Analysis
| EFAV | GSK | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 78% | 4 days ago 44% |
| Stochastic ODDS (%) | 4 days ago 80% | 4 days ago 46% |
| Momentum ODDS (%) | 4 days ago 68% | 4 days ago 67% |
| MACD ODDS (%) | 4 days ago 76% | 4 days ago 71% |
| TrendWeek ODDS (%) | 4 days ago 78% | 4 days ago 60% |
| TrendMonth ODDS (%) | 4 days ago 74% | 4 days ago 53% |
| Advances ODDS (%) | 4 days ago 76% | 4 days ago 59% |
| Declines ODDS (%) | 7 days ago 76% | N/A |
| BollingerBands ODDS (%) | N/A | 4 days ago 51% |
| Aroon ODDS (%) | 4 days ago 73% | 4 days ago 44% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
EFAV and
Correlation & Price change
A.I.dvisor indicates that over the last year, EFAV has been loosely correlated with HLN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if EFAV jumps, then HLN could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To EFAV | 1D Price Change % | ||
|---|---|---|---|---|
| EFAV | 100% | +0.59% | ||
| HLN - EFAV | 63% Loosely correlated | -0.41% | ||
| SAN - EFAV | 56% Loosely correlated | -0.52% | ||
| TEF - EFAV | 55% Loosely correlated | +0.95% | ||
| GSK - EFAV | 54% Loosely correlated | +2.25% | ||
| AZN - EFAV | 50% Loosely correlated | -0.10% | ||
More | ||||
GSK and
Correlation & Price change
A.I.dvisor indicates that over the last year, GSK has been loosely correlated with AZN. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then AZN could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y